Skip to main content
. Author manuscript; available in PMC: 2020 Apr 15.
Published in final edited form as: Clin Cancer Res. 2019 Jul 29;25(20):6170–6179. doi: 10.1158/1078-0432.CCR-19-0318

Figure 1: F. nucleatum expression in patients with ESCC.

Figure 1:

(A) The expression of F. nucleatum in 45 pairs of ESCC and adjacent normal tissue in the training cohort, and (B) in 48 pairs of the validation cohort. (C) The relative amount of F. nucleatum in 207 ESCC tissue according to T category in training cohort, and (D) in 344 ESCC tissue in validation cohort. *p<0.05; **p<0.01, ***p<0.001